SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)

CAPS Rating: 3 out of 5

A biopharmaceutical company, which is engaged in the development and commercialization of novel therapeutics to treat life-threatening diseases.

Recs

0
Player Avatar cfromberg (88.68) Submitted: 12/25/2006 6:01:27 AM : Outperform Start Price: $3.33 SCLN Score: +73.70

new managment is very capable of turning the comapany into a hidden gem.

Featured Broker Partners


Advertisement